Retinal disease in Usher syndrome III caused by mutations in the clarin-1 gene

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 6, 2008, Pages 2651-2660

  Herrera, Waldo ^a   Aleman, Tomas S ^a   Cideciyan, Artur V ^a   Roman, Alejandro J ^a   Banin, Eyal ^b   Ben Yosef, Tamar ^c   Gardner, Leigh M ^a   Sumaroka, Alexander ^a   Windsor, Elizabeth A M ^a   Schwartz, Sharon B ^a   Stone, Edwin M ^d   Liu, Xue Zhong ^e   Kimberling, William J ^f   Jacobson, Samuel G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f BOYS TOWN NATIONAL RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELL FUNCTION; CELL LOSS; CLARIN 1 GENE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; EYE EXAMINATION; FAMILY; FEMALE; GENE; HUMAN; KINETICS; MALE; MUTATION; NEAR INFRARED SPECTROSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHENOTYPE; PHOTORECEPTOR; POPULATION; PRIORITY JOURNAL; RETINA CONE; RETINA DETACHMENT; RETINA ROD; USHER SYNDROME; VISUAL DISORDER; ADOLESCENT; FLUORESCENCE; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; PERIMETRY; PHYSIOLOGY; RETINITIS PIGMENTOSA; VISUAL ACUITY; VISUAL FIELD;

CLRN1 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADOLESCENT; ADULT; AGED; FEMALE; FLUORESCENCE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PERIMETRY; PHOTORECEPTORS, VERTEBRATE; RETINITIS PIGMENTOSA; TOMOGRAPHY, OPTICAL COHERENCE; USHER SYNDROMES; VISUAL ACUITY; VISUAL FIELDS;

EID: 47249166431     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1505     Document Type: Article

References (58)

1. Williams DS. Usher syndrome: animal models, retinal function of Usher proteins, and prospects for gene therapy. Vision Res. 2008; 48: 433-441.
2. Fishman GA, Kumar A, Joseph ME, Torok N, Anderson RJ. Usher's syndrome: ophthalmic and neuro-otologic findings suggesting genetic heterogeneity. Arch Ophthalmol. 1983;101(9):1367-1374.
3. Kimberling WJ, Moller CG, Davenport SL, et al. Usher syndrome: clinical findings and gene localization studies. Laryngoscope. 1989;99(1):66-72. (Pubitemid 19036972)
4. Nuutila A. Dystrophia retinae pigmentosa-dysacusis syndrome (DRD): a study of the Usher- or Hallgren syndrome. J Genet Hum. 1970;18(1):57-88.
5. Gorlin RJ, Tilsner TJ, Feinstein S, Duvall AJ 3rd. Usher's syndrome type III. Arch Otolaryngol. 1979;105(6):353-354.
6. McDonald JM, Newsome DA, Rintelmann WF. Sensorineural hearing loss in patients with typical retinitis pigmentosa. Am J Ophthalmol. 1988;105(2):125-131. (Pubitemid 18081305)
7. Hope CI, Bundey S, Proops D, Fielder AR. Usher syndrome in the city of Birmingham: prevalence and clinical classification. Br J Ophthalmol. 1997;81(1):46-53. (Pubitemid 27068163)
8. Joensuu T, Hamalainen R, Lehesjoki AE, de la Chapelle A, Sankila EM. A sequence-ready map of the Usher syndrome type III critical region on chromosome 3q. Genomics. 2000;63(3):409-416. (Pubitemid 30146673)
9. Joensuu T, Hamalainen R, Yuan B, et al. Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3. Am J Hum Genet. 2001;69(4):673-684. (Pubitemid 32868513)
10. Adato A, Vreugde S, Joensuu T, et al. USH3A transcripts encode clarin-1, a four-transmembrane-domain protein with a possible role in sensory synapses. Eur J Hum Genet. 2002;10(6):339-350. (Pubitemid 34812289)
11. Fields RR, Zhou G, Huang D, et al. Usher syndrome type III: revised genomic structure of the USH3 gene and identification of novel mutations. Am J Hum Genet. 2002;71(3):607-617. (Pubitemid 34970131)
12. Aller E, Jaijo T, Oltra S, et al. Mutation screening of USH3 gene (clarin-1) in Spanish patients with Usher syndrome: low prevalence and phenotypic variability. Clin Genet. 2004;66(6):525-529. (Pubitemid 39562015)
13. Karjalainen S, Pakarinen L, Terasvirta M, Kaariainen H, Vartiainen E. Progressive hearing loss in Usher's syndrome. Ann Otol Rhinol Laryngol. 1989;98(11):863-866. (Pubitemid 19280829)
14. Pakarinen L, Karjalainen S, Simola KO, Laippala P, Kaitalo H. Usher's syndrome type 3 in Finland. Laryngoscope. 1995;105(6):613-617.
15. Ness SL, Ben-Yosef T, Bar-Lev A, et al. Genetic homogeneity and phenotypic variability among Ashkenazi Jews with Usher syndrome type III. J Med Genet. 2003;40(10):767-772. (Pubitemid 37311077)
16. Pennings RJ, Fields RR, Huygen PL, Deutman AF, Kimberling WJ, Cremers CW. Usher syndrome type III can mimic other types of Usher syndrome. Ann Otol Rhinol Laryngol. 2003;112(6):525-530. (Pubitemid 36712709)
17. Cohen M, Bitner-Glindzicz M, Luxon L. The changing face of Usher syndrome: clinical implications. Int J Audiol. 2007;46(2):82-93. (Pubitemid 46423634)
18. Pakarinen L, Tuppurainen K, Laippala P, Mantyjarvi M, Puhakka H. The ophthalmological course of Usher syndrome type III. Int Ophthalmol. 1996;19(5):307-311.
19. Plantinga RF, Pennings RJ, Huygen PL, et al. Visual impairment in Finnish Usher syndrome type III. Acta Ophthalmol Scand. 2006;84(1):36-41. (Pubitemid 43337471)
20. Schwartz SB, Aleman TS, Cideciyan AV, et al. Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotype. Invest Ophthalmol Vis Sci. 2005;46(2):734-743. (Pubitemid 40270360)
21. Jacobson SG, Voigt WJ, Parel JM, et al. Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology. 1986;93(12):1604-1611. (Pubitemid 17216939)
22. Jacobson SG, Yagasaki K, Feuer WJ, Román AJ. Interocular asymmetry of visual function in heterozygotes of X-linked retinitis pigmentosa. Exp Eye Res. 1989;48(5):679-691. (Pubitemid 19143450)
23. Roman AJ, Schwartz SB, Aleman TS, et al. Quantifying rod photoreceptor- mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures. Exp Eye Res. 2005;80(2):259-272.
24. Aleman TS, Cideciyan AV, Volpe NJ, Stevanin G, Brice A, Jacobson SG. Spinocerebellar ataxia type 7(SCA7) shows a cone-rod dystrophy phenotype. Exp Eye Res. 2002;74(6):737-745. (Pubitemid 34948373)
25. Cideciyan AV, Swider M, Aleman TS, et al. Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations. J Opt Soc Am A. 2007;24(5):1457-1467. (Pubitemid 46951573)
26. Weinberger AW, Lappas A, Kirschkamp T, et al. Fundus near infrared fluorescence correlates with fundus near infrared reflectance. Invest Ophthalmol Vis Sci. 2006;47(7):3098-3108.
27. Keilhauer CN, Delori FC. Near-infrared autofluorescence imaging of the fundus: visualization of ocular melanin. Invest Ophthalmol Vis Sci. 2006;47(8):3556-3564.
28. Cideciyan AV, Aleman TS, Jacobson SG, et al. Centrosomal-ciliary gene CEP290/NPHP6 mutations result in blindness with unexpected sparing of photoreceptors and visual brain: implications for therapy of Leber congenital amaurosis. Hum Mutat. 2007;28(11):1074-1083. (Pubitemid 350036911)
29. Huang Y, Cideciyan AV, Papastergiou GI, et al. Relation of optical coherence tomography to microanatomy in normal and rd chickens. Invest Ophthalmol Vis Sci. 1998;39(12):2405-2416. (Pubitemid 28485652)
30. Jacobson SG, Cideciyan AV, Aleman TS, et al. Crumbs homolog 1 (CRB1) mutations result in a thick human retina with abnormal lamination. Hum Mol Genet. 2003;12(9):1073-1078. (Pubitemid 36553527)
31. Jacobson SG, Cideciyan AV, Sumaroka A, et al. Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations. Invest Ophthalmol Vis Sci. 2006;47(9):4113-4120. (Pubitemid 46044330)
32. Aleman TS, Cideciyan AV, Sumaroka A, et al. Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations. Invest Ophthalmol Vis Sci. 2007;48(10):4759-4765.
33. Jacobson SG, Aleman TS, Cideciyan AV, et al. Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc Natl Acad Sci USA. 2005;102(17):6177-6182. (Pubitemid 40594274)
34. Sadeghi M, Cohn ES, Kimberling WJ, Tranebjaerg L, Möller C. Audiological and vestibular features in affected subjects with USH3: a genotype/phenotype correlation. Int J Audiol. 2005;44(5):307-316. (Pubitemid 40910782)
35. Berson EL, Sandberg MA, Rosner B, Birch DG, Hanson AH. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol. 1985;99(3):240-251. (Pubitemid 15143427)
36. Massof RW, Dagnelie G, Benzschawel T. First order dynamic of visual field loss in retinitis pigmentosa. Clin Vis Sci. 1990;5:1-26. (Pubitemid 20075821)
37. Grover S, Fishman GA, Anderson RJ, Alexander KR, Derlacki DJ. Rate of visual field loss in retinitis pigmentosa. Ophthalmology. 1997;104(3):460-465. (Pubitemid 27120301)
38. Birch DG, Anderson JL, Fish GE. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology. 1999;106(2):258-268. (Pubitemid 30191621)
39. Iannaccone A, Kritchevsky SB, Ciccarelli ML, et al. Kinetics of visual field loss in Usher syndrome type II. Invest Ophthalmol Vis Sci. 2004;45(3):784-792. (Pubitemid 38868371)
40. Fishman GA, Bozbeyoglu S, Massof RW, Kimberling W. Natural course of visual field loss in patients with Type 2 Usher syndrome. Retina. 2007;27(5):601-608. (Pubitemid 46905152)
41. Flynn MF, Fishman GA, Anderson RJ, Roberts DK. Retrospective longitudinal study of visual acuity change in patients with retinitis pigmentosa. Retina. 2001;21(6):639-646. (Pubitemid 34027779)
42. Piazza L, Fishman GA, Farber M, Derlacki D, Anderson RJ. Visual acuity loss in patients with Usher's syndrome. Arch Ophthalmol. 1986;104(9):1336-1339. (Pubitemid 16054963)
43. Edwards A, Fishman GA, Anderson RJ, Grover S, Derlacki DJ. Visual acuity and visual field impairment in Usher syndrome. Arch Ophthalmol. 1998;116(2):165-168. (Pubitemid 28113315)
44. Tsilou ET, Rubin BI, Caruso RC, et al. Usher syndrome clinical types I and II: could ocular symptoms and signs differentiate between the two types? Acta Ophthalmol Scand. 2002;80(2):196-201. (Pubitemid 34406855)
45. Sadeghi AM, Eriksson K, Kimberling WJ, Sjöström A, Möller C. Longterm visual prognosis in Usher syndrome types 1 and 2. Acta Ophthalmol Scand. 2006;84(4):537-544. (Pubitemid 44102853)
46. Jacobson SG, Cideciyan AV, Aleman TS, et al. Leber congenital amaurosis caused by RPGRIP1 mutation shows treatment potential. Ophthalmology. 2007;114(5):895-898. (Pubitemid 46656404)
47. Jacobson SG, Sumaroka A, Aleman TS, Cideciyan AV, Danciger M, Farber DB. Evidence for retinal remodelling in retinitis pigmentosa caused by PDE6B mutation. Br J Ophthalmol. 2007;91(5):699-701. (Pubitemid 46716553)
48. Reiners J, Nagel-Wolfrum K, Jurgens K, Marker T, Wolfrum U. Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease. Exp Eye Res. 2006;83(1):97-119. (Pubitemid 43783252)
49. Kremer H, van Wijk E, Marker T, Wolfrum U, Roepman R. Usher syndrome: molecular links of pathogenesis, proteins and pathways. Hum Mol Genet. 2006;15:R262-R270. (Pubitemid 44446802)
50. Maerker T, van Wijk EV, Overlack N, et al. A novel Usher protein network at the periciliary reloading point between molecular transport machineries in vertebrate photoreceptor cells. Hum Mol Genet. 2008;17;71-86.
51. Roepman R, Wolfrum U. Protein networks and complexes in photoreceptor cilia. Subcell Biochem. 2007;43:209-235.
52. Liu X, Bulgakov OV, Darrow KN, et al. Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells. Proc Natl Acad Sci USA. 2007;104(11):4413-4418. (Pubitemid 47186240)
53. Aarnisalo AA, Pietola L, Joensuu J, et al. Anti-clarin-1 AAV-delivered ribozyme induced apoptosis in the mouse cochlea. Hear Res. 2007;230(1-2):9-16. (Pubitemid 47058833)
54. Milam AH, Li ZY, Fariss RN. Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res. 1998;17(2):175-205. (Pubitemid 28339912)
55. Weiter JJ, Delori F, Dorey CK. Central sparing in annular macular degeneration. Am J Ophthalmol. 1988;106(3):286-292. (Pubitemid 18220907)
56. Cideciyan AV, Swider M, Aleman TS, et al. ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina. Invest Ophthalmol Vis Sci. 2005;46(12):4739-4746. (Pubitemid 44264579)
57. Pennings RJ, Huygen PL, Orten DJ, et al. Evaluation of visual impairment in Usher syndrome 1b and Usher syndrome 2a. Acta Ophthalmol Scand. 2004;82(2):131-139. (Pubitemid 38515365)
58. Stone EM. Leber congenital amaurosis: a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture. Am J Ophthalmol. 2007;144;791-811. (Pubitemid 350122365)